Advanced technologies for the molecular diagnosis of fragile X syndrome

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Fragile X syndrome (FXS), a trinucleotide repeat disorder, is the most common heritable form of cognitive impairment. Since the discovery of the FMR1 gene in 1991, great strides have been made in the field of molecular diagnosis for FXS. Cytogenetic analysis, which was the method of diagnosis in the early 1990, was replaced by Southern blot and PCR analysis albeit with some limitations. In the past few years many PCR-based methodologies, able to amplify large full mutation expanded alleles, with or without methylation, have been proposed. Reviewed here are the advantages, disadvantages and limitations of the most recent developments in the field of FXS diagnosis.

Original languageEnglish (US)
Pages (from-to)1465-1473
Number of pages9
JournalExpert Review of Molecular Diagnostics
Volume15
Issue number11
DOIs
StatePublished - Nov 2 2015

Fingerprint

Fragile X Syndrome
Technology
Trinucleotide Repeats
Polymerase Chain Reaction
Cytogenetic Analysis
Genetic Association Studies
Southern Blotting
Methylation
Alleles
Mutation

Keywords

  • AGG interruption
  • CGG repeat
  • FXS
  • methylation
  • premutation
  • Southern Blot
  • triplet-primed PCR

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this

Advanced technologies for the molecular diagnosis of fragile X syndrome. / Tassone, Flora.

In: Expert Review of Molecular Diagnostics, Vol. 15, No. 11, 02.11.2015, p. 1465-1473.

Research output: Contribution to journalArticle

@article{b1e712c2709f416fbe44ef3e994575b0,
title = "Advanced technologies for the molecular diagnosis of fragile X syndrome",
abstract = "Fragile X syndrome (FXS), a trinucleotide repeat disorder, is the most common heritable form of cognitive impairment. Since the discovery of the FMR1 gene in 1991, great strides have been made in the field of molecular diagnosis for FXS. Cytogenetic analysis, which was the method of diagnosis in the early 1990, was replaced by Southern blot and PCR analysis albeit with some limitations. In the past few years many PCR-based methodologies, able to amplify large full mutation expanded alleles, with or without methylation, have been proposed. Reviewed here are the advantages, disadvantages and limitations of the most recent developments in the field of FXS diagnosis.",
keywords = "AGG interruption, CGG repeat, FXS, methylation, premutation, Southern Blot, triplet-primed PCR",
author = "Flora Tassone",
year = "2015",
month = "11",
day = "2",
doi = "10.1586/14737159.2015.1101348",
language = "English (US)",
volume = "15",
pages = "1465--1473",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Advanced technologies for the molecular diagnosis of fragile X syndrome

AU - Tassone, Flora

PY - 2015/11/2

Y1 - 2015/11/2

N2 - Fragile X syndrome (FXS), a trinucleotide repeat disorder, is the most common heritable form of cognitive impairment. Since the discovery of the FMR1 gene in 1991, great strides have been made in the field of molecular diagnosis for FXS. Cytogenetic analysis, which was the method of diagnosis in the early 1990, was replaced by Southern blot and PCR analysis albeit with some limitations. In the past few years many PCR-based methodologies, able to amplify large full mutation expanded alleles, with or without methylation, have been proposed. Reviewed here are the advantages, disadvantages and limitations of the most recent developments in the field of FXS diagnosis.

AB - Fragile X syndrome (FXS), a trinucleotide repeat disorder, is the most common heritable form of cognitive impairment. Since the discovery of the FMR1 gene in 1991, great strides have been made in the field of molecular diagnosis for FXS. Cytogenetic analysis, which was the method of diagnosis in the early 1990, was replaced by Southern blot and PCR analysis albeit with some limitations. In the past few years many PCR-based methodologies, able to amplify large full mutation expanded alleles, with or without methylation, have been proposed. Reviewed here are the advantages, disadvantages and limitations of the most recent developments in the field of FXS diagnosis.

KW - AGG interruption

KW - CGG repeat

KW - FXS

KW - methylation

KW - premutation

KW - Southern Blot

KW - triplet-primed PCR

UR - http://www.scopus.com/inward/record.url?scp=84947126569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947126569&partnerID=8YFLogxK

U2 - 10.1586/14737159.2015.1101348

DO - 10.1586/14737159.2015.1101348

M3 - Article

C2 - 26489042

AN - SCOPUS:84947126569

VL - 15

SP - 1465

EP - 1473

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 11

ER -